logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/pembrolizumabAutoimmune colitis and pancreatitis: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2016年 / 1617卷 / 1期
关键词:
D O I:
10.1007/s40278-016-20924-1
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:145 / 145
相关论文
共 50 条
  • [21] Ipilimumab/pembrolizumabGranulomatous colitis: case report
    Reactions Weekly, 2021, 1860 (1) : 206 - 206
  • [22] Ipilimumab/nivolumabHyperthyreosis and colitis: case report
    Reactions Weekly, 2022, 1923 (1) : 269 - 269
  • [23] Ipilimumab/nivolumabRecurrent colitis: case report
    Reactions Weekly, 2021, 1865 (1) : 239 - 239
  • [24] PembrolizumabAutoimmune diabetes mellitus type 1 and colitis: case report
    Reactions Weekly, 2019, 1743 (1) : 178 - 178
  • [25] Ipilimumab/nivolumab/relatlimabColitis and pancreatitis: case report
    Reactions Weekly, 2020, 1803 (1) : 146 - 146
  • [26] Ipilimumab/NivolumabAutoimmune colitis and pseudoprogression: case report
    Reactions Weekly, 2025, 2045 (1) : 201 - 201
  • [27] Ipilimumab/nivolumabHepatitis, rash and colitis: case report
    Reactions Weekly, 2019, 1741 (1) : 143 - 143
  • [28] Ipilimumab/nivolumabGrade 3 colitis: case report
    Reactions Weekly, 2023, 1986 (1) : 222 - 222
  • [29] PembrolizumabAutoimmune haemolytic anaemia and immune-mediated colitis: case report
    Reactions Weekly, 2021, 1854 (1) : 295 - 295
  • [30] Colestyramine/ipilimumab/nivolumabMasking of colitis: case report
    Reactions Weekly, 2021, 1841 (1) : 82 - 82
← 12345 →